Tech Company Financing Transactions
NephroGenex Funding Round
Care Capital and Healthcap Venture Capital invested in a $1 million venture round for NephroGenex. The financing was announced on 9/30/2010.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Care Capital (Richard Markham)
Healthcap Venture Capital (Eugen Steiner)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3200 Beechleaf Ct. 900
Raleigh, NC 27604
USA
Raleigh, NC 27604
USA
Phone
Website
Email Address
Overview
NephroGenex (NASDAQ: NRX) is a biotechnology company applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Isdale
Browse more venture capital transactions:
Prev: 9/30/2010: BrightSource Energy venture capital transaction
Next: 9/30/2010: BioMers Pte venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs